We are pleased to share that the January 2019 issue of Pancreas features an article titled “Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosome,” written by the Director […]
Global Research Collaboration for Early Diagnosis
Currently, pancreatic cancer has the highest mortality rate of all major cancers with 74% of all patients losing their battle within the first year of diagnosis. There is clear evidence […]
Hirshberg Foundation Funds Study Focused on Pancreatic Cancer Patient & Caregiver Well-Being
The “Living with Pancreatic Cancer: Patient And Caregiver Experiences Study (PACES),” conducted by Annette Stanton, PhD investigates the physical and psychological factors that contribute to overall wellness. PACES continues Dr. […]
Novel Hirshberg Foundation Grant to Focus on Care for Pancreatic Cancer Patients
Pancreatic cancer remains one of the deadliest of all cancers, with a five-year survival rate of around 4 percent. It’s no wonder that battling the disease takes a toll on […]
New research sheds light on pancreatic cancer biology & role of common p53 mutation
New research from Seed Grant recipient, Marina Pasca di Magliano, PhD, from the University of Michigan has deepened our understanding of the biology of pancreatic cancer, crucial to the development […]
New study establishes that ATM activity poses a major barrier to the development of cancer in the pancreas by maintaining genomic stability.
A new study published by our 2014-15 Seed Grant recipient, Yiannis Drosos, PhD has uncovered information that can help diagnose and treat pancreatic cancer tumors.